1.
Design and Baseline Characteristics of the Simvastatin and Ezetimibe in Aortic Stenosis (SEAS) Study
by Rossebø, Anne B., MD
The American journal of cardiology, 2007, Vol.99 (7), p.970-973
2.
Interpretation of the evidence for the efficacy and safety of statin therapy
by Collins, Rory, Prof
The Lancet (British edition), 2016, Vol.388 (10059), p.2532-2561
3.
Modulation of Adhesion Molecules by Cholesterol‐Lowering Therapy in Mononuclear Cells from Hypercholesterolemic Patients
by Cerda, Alvaro
Cardiovascular therapeutics, 2015-08, Vol.33 (4), p.168-176
4.
Efficacy and tolerability of adding prescription Omega-3 fatty acids 4 g/d to Simvastatin 40 mg/d in hypertriglyceridemic patients: An 8-week, randomized, double-blind, placebo-con...
by Davidson, Michael H., MD
Clinical therapeutics, 2007, Vol.29 (7), p.1354-1367
5.
Effects of a polypill (Polycap) on risk factors in middle-aged individuals without cardiovascular disease (TIPS): a phase II, double-blind, randomised trial
by Yusuf, S
The Lancet (British edition), 2009, Vol.373 (9672), p.1341-1351
6.
Rationale and design of IMPROVE-IT (IMProved Reduction of Outcomes: Vytorin Efficacy International Trial): Comparison of ezetimbe/simvastatin versus simvastatin monotherapy on card...
by Cannon, Christopher P., MD
The American heart journal, 2008, Vol.156 (5), p.826-832
7.
A Population-Based Cohort Study on the Drug-Specific Effect of Statins on Sepsis Outcome
by Lee, Chien-Chang
Chest, 2018-04, Vol.153 (4), p.805-815
8.
Update on rifampin, rifabutin, and rifapentine drug interactions
by Baciewicz, Anne M
Current medical research and opinion, 2013-01, Vol.29 (1), p.1-12
9.
Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR Trial)
by Jones, Peter H
The American journal of cardiology, 2003, Vol.92 (2), p.152-160
10.
Effects on 11-year mortality and morbidity of lowering LDL cholesterol with simvastatin for about 5 years in 20 536 high-risk individuals: a randomised controlled trial
by Group, Heart Protection Study Collaborative
The Lancet (British edition), 2011, Vol.378 (9808), p.2013-2020
11.
Study of Heart and Renal Protection (SHARP): Randomized trial to assess the effects of lowering low-density lipoprotein cholesterol among 9,438 patients with chronic kidney disease
by Group, Sharp Collaborative
The American heart journal, 2010, Vol.160 (5), p.785-794.e10
12.
Evaluating cardiovascular event reduction with ezetimibe as an adjunct to simvastatin in 18,144 patients after acute coronary syndromes: Final baseline characteristics of the IMPRO...
by Blazing, Michael A., MD
The American heart journal, 2014, Vol.168 (2), p.205-212.e1
13.
A VOYAGER Meta-Analysis of the Impact of Statin Therapy on Low-Density Lipoprotein Cholesterol and Triglyceride Levels in Patients With Hypertriglyceridemia
by Karlson, Björn W
The American journal of cardiology, 2016-05-01, Vol.117 (9), p.1444-1448
14.
Molecular Lipids Identify Cardiovascular Risk and Are Efficiently Lowered by Simvastatin and PCSK9 Deficiency
by Tarasov, Kirill
The journal of clinical endocrinology and metabolism, 2014-01, Vol.99 (1), p.E45-E52
15.
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial
by Rory Collins
The Lancet (British edition), 2002-07-06, Vol.360 (9326), p.7-22
16.
Effect of ETC-1002 on Serum Low-Density Lipoprotein Cholesterol in Hypercholesterolemic Patients Receiving Statin Therapy
by Ballantyne, Christie M., MD
The American journal of cardiology, 2016, Vol.117 (12), p.1928-1933
17.
MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial
by Collins, Rory
The Lancet (British edition), 2003, Vol.361 (9374), p.2005-2016
18.
Statins enhance the anti-inflammatory effects of inhaled corticosteroids in asthmatic patients through increased induction of indoleamine 2, 3-dioxygenase
by Maneechotesuwan, Kittipong, MD, PhD
Journal of allergy and clinical immunology, 2010, Vol.126 (4), p.754-762.e1
19.
Relation of Variability of Low-Density Lipoprotein Cholesterol and Blood Pressure to Events in Patients With Previous Myocardial Infarction from the IDEAL Trial
by Bangalore, Sripal
The American journal of cardiology, 2017-02-01, Vol.119 (3), p.379-387
20.
C-reactive protein concentration and the vascular benefits of statin therapy: an analysis of 20 536 patients in the Heart Protection Study
by Group, Heart Protection Study Collaborative
The Lancet (British edition), 2011, Vol.377 (9764), p.469-476
